![](/images/general/no_picture/200_user.png)
Chandrika Prasad
Examiner (ID: 17499, Phone: (571)272-2099 , Office: P/2831 )
Most Active Art Unit | 2839 |
Art Unit(s) | 2833, 2839, 2831 |
Total Applications | 2897 |
Issued Applications | 2445 |
Pending Applications | 55 |
Abandoned Applications | 397 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
09/902135 | Peptide for regulation of tissue plasminogen activator | Jul 9, 2001 | Abandoned |
Array
(
[id] => 1331841
[patent_doc_number] => 06596543
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-07-22
[patent_title] => 'Use of liposomes of defined composition and size for the preparation of prothrombin time reagents'
[patent_app_type] => B2
[patent_app_number] => 09/815398
[patent_app_country] => US
[patent_app_date] => 2001-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4299
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/596/06596543.pdf
[firstpage_image] =>[orig_patent_app_number] => 09815398
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/815398 | Use of liposomes of defined composition and size for the preparation of prothrombin time reagents | Mar 21, 2001 | Issued |
Array
(
[id] => 1217242
[patent_doc_number] => 06706861
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-03-16
[patent_title] => 'Reconstitution of purified membrane proteins into preformed liposomes'
[patent_app_type] => B2
[patent_app_number] => 09/815195
[patent_app_country] => US
[patent_app_date] => 2001-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7758
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/706/06706861.pdf
[firstpage_image] =>[orig_patent_app_number] => 09815195
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/815195 | Reconstitution of purified membrane proteins into preformed liposomes | Mar 21, 2001 | Issued |
Array
(
[id] => 7060992
[patent_doc_number] => 20050003353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 09/809889
[patent_app_country] => US
[patent_app_date] => 2001-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 35504
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20050003353.pdf
[firstpage_image] =>[orig_patent_app_number] => 09809889
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/809889 | Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor. | Mar 15, 2001 | Issued |
Array
(
[id] => 7060991
[patent_doc_number] => 20050003352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 09/809827
[patent_app_country] => US
[patent_app_date] => 2001-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 35500
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20050003352.pdf
[firstpage_image] =>[orig_patent_app_number] => 09809827
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/809827 | Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor | Mar 15, 2001 | Issued |
Array
(
[id] => 773151
[patent_doc_number] => 07001729
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-02-21
[patent_title] => 'Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor'
[patent_app_type] => utility
[patent_app_number] => 09/811131
[patent_app_country] => US
[patent_app_date] => 2001-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 20
[patent_no_of_words] => 35580
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/001/07001729.pdf
[firstpage_image] =>[orig_patent_app_number] => 09811131
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/811131 | Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor | Mar 13, 2001 | Issued |
Array
(
[id] => 1021236
[patent_doc_number] => 06887670
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-03
[patent_title] => 'Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor'
[patent_app_type] => utility
[patent_app_number] => 09/811132
[patent_app_country] => US
[patent_app_date] => 2001-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 20
[patent_no_of_words] => 35558
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/887/06887670.pdf
[firstpage_image] =>[orig_patent_app_number] => 09811132
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/811132 | Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor | Mar 13, 2001 | Issued |
Array
(
[id] => 7612926
[patent_doc_number] => 06902908
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-06-07
[patent_title] => 'Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor'
[patent_app_type] => utility
[patent_app_number] => 09/811094
[patent_app_country] => US
[patent_app_date] => 2001-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 20
[patent_no_of_words] => 35592
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/902/06902908.pdf
[firstpage_image] =>[orig_patent_app_number] => 09811094
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/811094 | Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor | Mar 13, 2001 | Issued |
Array
(
[id] => 1157900
[patent_doc_number] => 06762286
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-07-13
[patent_title] => 'Modified vitamin K-dependent polypeptides'
[patent_app_type] => B2
[patent_app_number] => 09/803810
[patent_app_country] => US
[patent_app_date] => 2001-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 24
[patent_no_of_words] => 17641
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/762/06762286.pdf
[firstpage_image] =>[orig_patent_app_number] => 09803810
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/803810 | Modified vitamin K-dependent polypeptides | Mar 11, 2001 | Issued |
Array
(
[id] => 1021700
[patent_doc_number] => 06887845
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-03
[patent_title] => 'Polypeptoid pulmonary surfactants'
[patent_app_type] => utility
[patent_app_number] => 09/788308
[patent_app_country] => US
[patent_app_date] => 2001-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 20
[patent_no_of_words] => 11062
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/887/06887845.pdf
[firstpage_image] =>[orig_patent_app_number] => 09788308
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/788308 | Polypeptoid pulmonary surfactants | Feb 15, 2001 | Issued |
Array
(
[id] => 6242182
[patent_doc_number] => 20020045211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'Direct expression of peptides into culture media'
[patent_app_type] => new
[patent_app_number] => 09/780643
[patent_app_country] => US
[patent_app_date] => 2001-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 14903
[patent_no_of_claims] => 101
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20020045211.pdf
[firstpage_image] =>[orig_patent_app_number] => 09780643
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/780643 | Direct expression of peptides into culture media | Feb 8, 2001 | Issued |
Array
(
[id] => 1296961
[patent_doc_number] => 06627438
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-09-30
[patent_title] => 'Direct expression of peptides into culture media'
[patent_app_type] => B2
[patent_app_number] => 09/780878
[patent_app_country] => US
[patent_app_date] => 2001-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 38
[patent_no_of_words] => 14670
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/627/06627438.pdf
[firstpage_image] =>[orig_patent_app_number] => 09780878
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/780878 | Direct expression of peptides into culture media | Feb 8, 2001 | Issued |
Array
(
[id] => 425273
[patent_doc_number] => 07271256
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-09-18
[patent_title] => 'Method for producing circular or multimeric protein species in vivo or in vitro and related methods'
[patent_app_type] => utility
[patent_app_number] => 09/937070
[patent_app_country] => US
[patent_app_date] => 2001-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9130
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/271/07271256.pdf
[firstpage_image] =>[orig_patent_app_number] => 09937070
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/937070 | Method for producing circular or multimeric protein species in vivo or in vitro and related methods | Jan 30, 2001 | Issued |
Array
(
[id] => 6912236
[patent_doc_number] => 20050175994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Methods and materials relating to prothrombinase-like polypeptides and polynucleotides'
[patent_app_type] => utility
[patent_app_number] => 10/311827
[patent_app_country] => US
[patent_app_date] => 2000-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 46757
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20050175994.pdf
[firstpage_image] =>[orig_patent_app_number] => 10311827
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/311827 | Methods and materials relating to prothrombinase-like polypeptides and polynucleotides | Dec 21, 2000 | Abandoned |
Array
(
[id] => 6761888
[patent_doc_number] => 20030125250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Medicinal compositions for preventing and treating hemorrhagic diseases associating thrombopathy'
[patent_app_type] => new
[patent_app_number] => 10/168727
[patent_app_country] => US
[patent_app_date] => 2002-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2696
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20030125250.pdf
[firstpage_image] =>[orig_patent_app_number] => 10168727
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/168727 | Medicinal compositions for preventing and treating hemorrhagic diseases associating thrombopathy | Dec 20, 2000 | Issued |
Array
(
[id] => 6224497
[patent_doc_number] => 20020004228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-10
[patent_title] => 'Zvwf1: a member of the von willebrand factor type A domain superfamily'
[patent_app_type] => new
[patent_app_number] => 09/732227
[patent_app_country] => US
[patent_app_date] => 2000-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29999
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20020004228.pdf
[firstpage_image] =>[orig_patent_app_number] => 09732227
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/732227 | Zvwf1: a member of the von willebrand factor type A domain superfamily | Dec 6, 2000 | Abandoned |
Array
(
[id] => 723856
[patent_doc_number] => 07045280
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-16
[patent_title] => 'Assay method'
[patent_app_type] => utility
[patent_app_number] => 10/130368
[patent_app_country] => US
[patent_app_date] => 2000-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4277
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/045/07045280.pdf
[firstpage_image] =>[orig_patent_app_number] => 10130368
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/130368 | Assay method | Dec 4, 2000 | Issued |
Array
(
[id] => 1271670
[patent_doc_number] => 06653449
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-25
[patent_title] => 'Hemolytic active proteins and genes encoding the same'
[patent_app_type] => B1
[patent_app_number] => 09/647522
[patent_app_country] => US
[patent_app_date] => 2000-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8081
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/653/06653449.pdf
[firstpage_image] =>[orig_patent_app_number] => 09647522
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/647522 | Hemolytic active proteins and genes encoding the same | Nov 30, 2000 | Issued |
Array
(
[id] => 6621842
[patent_doc_number] => 20020065214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-30
[patent_title] => 'Method of treating congestive heart failure'
[patent_app_type] => new
[patent_app_number] => 09/725161
[patent_app_country] => US
[patent_app_date] => 2000-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1636
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20020065214.pdf
[firstpage_image] =>[orig_patent_app_number] => 09725161
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/725161 | Method of treating congestive heart failure | Nov 28, 2000 | Abandoned |
Array
(
[id] => 1337208
[patent_doc_number] => 06593294
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-15
[patent_title] => 'Pharmaceutical composition comprising Factor VIII and neutral liposomes'
[patent_app_type] => B1
[patent_app_number] => 09/673412
[patent_app_country] => US
[patent_app_date] => 2000-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4674
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/593/06593294.pdf
[firstpage_image] =>[orig_patent_app_number] => 09673412
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/673412 | Pharmaceutical composition comprising Factor VIII and neutral liposomes | Nov 21, 2000 | Issued |